Doliente, Michelle .

HRN: 05-68-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2023
CEFUROXIME 1.5GM (VIAL)
07/12/2023
07/19/2023
IV
1.5
On Call Or
For CS
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: